Adalimumab Reduces Epicardial Adipose Tissue in Psoriasis: A Post Hoc Analysis of a Randomized Placebo-Controlled Clinical Trial.

Ramessur R, Kernizan F, Ranjbar E, Mehta NN, Alavi A, Shin DB, Iacobellis G, Gelfand JM

Open source

DOI
10.2147/ptt.s628498
Published
2026
Container
Psoriasis (Auckland, N.Z.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ptt.s628498,
  title = {Adalimumab Reduces Epicardial Adipose Tissue in Psoriasis: A Post Hoc Analysis of a Randomized Placebo-Controlled Clinical Trial.},
  author = {Ramessur R and Kernizan F and Ranjbar E and Mehta NN and Alavi A and Shin DB and Iacobellis G and Gelfand JM},
  year = {2026},
  journal = {Psoriasis (Auckland, N.Z.)},
  doi = {10.2147/ptt.s628498},
  url = {https://doi.org/10.2147/ptt.s628498}
}

RIS

TY  - JOUR
TI  - Adalimumab Reduces Epicardial Adipose Tissue in Psoriasis: A Post Hoc Analysis of a Randomized Placebo-Controlled Clinical Trial.
AU  - Ramessur R
AU  - Kernizan F
AU  - Ranjbar E
AU  - Mehta NN
AU  - Alavi A
AU  - Shin DB
AU  - Iacobellis G
AU  - Gelfand JM
PY  - 2026
JO  - Psoriasis (Auckland, N.Z.)
DO  - 10.2147/ptt.s628498
UR  - https://doi.org/10.2147/ptt.s628498
ER  - 

APA

R, R., F, K., E, R., NN, M., A, A., DB, S., G, I., & JM, G. (2026). Adalimumab Reduces Epicardial Adipose Tissue in Psoriasis: A Post Hoc Analysis of a Randomized Placebo-Controlled Clinical Trial.. Psoriasis (Auckland, N.Z.). https://doi.org/10.2147/ptt.s628498

Source records